Home > Qtrly Results > AUROBINDO PHARMA

AUROBINDO PHARMA
Quarterly Results Analysis [Mar2025]

AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Quarterly Results

Consolidated Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Revenues ₹8,382 Cr ₹7,979 Cr ₹7,796 Cr ₹7,567 Cr ₹7,580 Cr ₹7,352 Cr ₹7,219 Cr ₹6,851 Cr
Expenses ₹6,590 Cr ₹6,401 Cr ₹6,230 Cr ₹5,947 Cr ₹5,907 Cr ₹5,750 Cr ₹5,846 Cr ₹5,699 Cr
Operating Income ₹1,792 Cr ₹1,578 Cr ₹1,566 Cr ₹1,620 Cr ₹1,673 Cr ₹1,601 Cr ₹1,373 Cr ₹1,151 Cr
Other Income ₹135 Cr ₹157 Cr ₹136 Cr ₹221 Cr ₹136 Cr ₹163 Cr ₹187 Cr ₹116 Cr
Interest ₹115 Cr ₹118 Cr ₹113 Cr ₹111 Cr ₹89 Cr ₹76 Cr ₹68 Cr ₹57 Cr
Depreciation ₹444 Cr ₹419 Cr ₹382 Cr ₹404 Cr ₹354 Cr ₹423 Cr ₹418 Cr ₹327 Cr
Profit Before Tax ₹1,367 Cr ₹1,198 Cr ₹1,207 Cr ₹1,325 Cr ₹1,243 Cr ₹1,265 Cr ₹1,075 Cr ₹815 Cr
Profit After Tax ₹935 Cr ₹844 Cr ₹817 Cr ₹920 Cr ₹920 Cr ₹943 Cr ₹751 Cr ₹573 Cr
EPS ₹15.56 ₹14.56 ₹14.07 ₹15.69 ₹15.51 ₹15.98 ₹12.92 ₹9.74
Industry Peers & Returns1W1M1Y
AUROBINDO PHARMA -4.2% -7.8% -12.7%
SUN PHARMACEUTICAL INDUSTRIES -1.3% -3.3% 8.3%
DIVIS LABORATORIES -1.5% 0.8% 42.3%
CIPLA -1.7% 2.3% -5.8%
TORRENT PHARMACEUTICALS -3.3% -1.4% 9.8%
DR REDDYS LABORATORIES -1.6% 8.4% 10.6%
MANKIND PHARMA -3.3% -6.1% 3.4%
ZYDUS LIFESCIENCES -1.8% 5.9% -12%
LUPIN -3.2% -1.1% 22.1%

AUROBINDO PHARMA Quarterly Revenues

Revenues
Q-o-Q

5.06 %

Y-o-Y

10.58 %

Quarters Revenues % Change
Mar2025 ₹8,382 Cr
5.06
Dec2024 ₹7,979 Cr
2.34
Sep2024 ₹7,796 Cr
3.03
Jun2024 ₹7,567 Cr
-0.17
Mar2024 ₹7,580 Cr
3.11
Dec2023 ₹7,352 Cr
1.83
Sep2023 ₹7,219 Cr
5.38
Jun2023 ₹6,851 Cr -

AUROBINDO PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

13.56 %

Y-o-Y

7.12 %

Quarters Operating Profit % Change
Mar2025 ₹1,792 Cr
13.56
Dec2024 ₹1,578 Cr
0.76
Sep2024 ₹1,566 Cr
-3.30
Jun2024 ₹1,620 Cr
-3.18
Mar2024 ₹1,673 Cr
4.47
Dec2023 ₹1,601 Cr
16.59
Sep2023 ₹1,373 Cr
19.29
Jun2023 ₹1,151 Cr -
Operating Margins
Q-o-Q

8.09 %

Y-o-Y

-3.13 %

Quarters Operating Margin% % Change
Mar2025 21.38%
8.09
Dec2024 19.78%
-1.54
Sep2024 20.09%
-6.12
Jun2024 21.4%
-3.04
Mar2024 22.07%
1.33
Dec2023 21.78%
14.51
Sep2023 19.02%
13.15
Jun2023 16.81% -

AUROBINDO PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

10.79 %

Y-o-Y

1.63 %

Quarters Profit After Tax % Change
Mar2025 ₹935 Cr
10.79
Dec2024 ₹844 Cr
3.35
Sep2024 ₹817 Cr
-11.20
Jun2024 ₹920 Cr
-0.04
Mar2024 ₹920 Cr
-2.39
Dec2023 ₹943 Cr
25.50
Sep2023 ₹751 Cr
31.18
Jun2023 ₹573 Cr -
PAT Margins
Q-o-Q

5.39 %

Y-o-Y

-8.15 %

Quarters PAT Margin(%) % Change
Mar2025 11.15 %
5.39
Dec2024 10.58 %
0.95
Sep2024 10.48 %
-13.74
Jun2024 12.15 %
0.08
Mar2024 12.14 %
-5.30
Dec2023 12.82 %
23.27
Sep2023 10.4 %
24.40
Jun2023 8.36 % -

AUROBINDO PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

6.87 %

Y-o-Y

0.32 %

Quarters EPS % Change
Mar2025 ₹15.56
6.87
Dec2024 ₹14.56
3.48
Sep2024 ₹14.07
-10.33
Jun2024 ₹15.69
1.16
Mar2024 ₹15.51
-2.94
Dec2023 ₹15.98
23.68
Sep2023 ₹12.92
32.65
Jun2023 ₹9.74 -

You may also like the below Video Courses